financetom
Business
financetom
/
Business
/
Victoria's Secret Q1 Adjusted EPS, Net Sales Decrease; Q2 Outlook Issued
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Victoria's Secret Q1 Adjusted EPS, Net Sales Decrease; Q2 Outlook Issued
Jun 5, 2024 2:12 PM

04:55 PM EDT, 06/05/2024 (MT Newswires) -- Victoria's Secret (VSCO) reported Q1 adjusted earnings late Wednesday of $0.12 per diluted share, down from $0.28 a year earlier.

Analysts polled by Capital IQ expected $0.12.

Net sales for the quarter ended May 4 were $1.36 billion, down from $1.41 billion a year earlier.

Analysts surveyed by Capital IQ expected $1.36 billion.

The company said it expects Q2 adjusted diluted EPS between $0.05 and $0.20. Analysts polled by Capital IQ expect $0.06.

The company said it reaffirmed its fiscal year 2024 guidance and still expects net sales to be about $6 billion. Analysts surveyed by Capital IQ expect $6 billion.

Victoria's Secret also said that proxy advisory firms are recommending that its shareholders vote in favor of the election of all its director nominees, compensation of its named executive officers, and amendment to increase the number of shares available for issuance.

The annual shareholder meeting is slated for June 13.

Price: 22.70, Change: +0.09, Percent Change: +0.40

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: HSBC Reviewing China Digital Wealth Business' Expenses, Control
Market Chatter: HSBC Reviewing China Digital Wealth Business' Expenses, Control
Oct 17, 2024
10:31 AM EDT, 10/14/2024 (MT Newswires) -- HSBC Holdings ( HSBC ) started a review of expenses and operational controls at its China digital wealth business Pinnacle a few months ago, Reuters reported Monday, citing several unnamed sources. The bank is looking into staff salary structures and whether suppliers inflated expenses, adding to a sharp increase in costs that exceeded...
Treace Medical Concepts Sues Stryker for Patent Infringement
Treace Medical Concepts Sues Stryker for Patent Infringement
Oct 17, 2024
10:41 AM EDT, 10/14/2024 (MT Newswires) -- Treace Medical Concepts ( TMCI ) said Monday it filed a lawsuit against Stryker (SYK) and its Wright Medical Technology subsidiary for allegedly infringing nine patents related to Treace's Lapiplasty 3D bunion correction technologies. The lawsuit, lodged in the US District Court for the District of New Jersey, seeks injunctive relief and damages,...
Cycle Pharma maintains takeover offer for Vanda Pharmaceuticals
Cycle Pharma maintains takeover offer for Vanda Pharmaceuticals
Oct 17, 2024
Oct 14 (Reuters) - UK-based Cycle Pharmaceuticals on Monday reaffirmed its offer to buy Vanda Pharmaceuticals ( VNDA ) in a deal that values the US drugmaker at $488 million, despite a regulatory setback for its stomach condition drug in September. Vanda in June rejected takeover offers from Cycle Pharma and a revised bid from contract manufacturer Future Pak. WHY...
Affirm Holdings to Benefit From Lower Interest Rate Environment, Wedbush Securities Says
Affirm Holdings to Benefit From Lower Interest Rate Environment, Wedbush Securities Says
Oct 17, 2024
10:32 AM EDT, 10/14/2024 (MT Newswires) -- Affirm Holdings ( AFRM ) is set to benefit from a lower interest rate environment, leading to lower funding costs and incremental growth in gross merchandise volume, or GMV, among others, Wedbush Securities said in a note to clients early Monday. The company has a balanced risk/reward and a number of ancillary GMV...
Copyright 2023-2026 - www.financetom.com All Rights Reserved